The plant cell growth company

 

Our patented biofarming technology enables us to produce specific types of plant cells without having to grow the plant. This means low cost and high-quality core ingredients for pharmaceutical, nutraceutical and supplement producers
BioHarvest Sciences has a clear Path to Commercialization:


  • Manufacturing agreement with Sugart to provide 20 Ton capacity facility for 2021

  • September 2020 – signed US Distribution agreement with Batory Foods for up to $18 Million of Vinia over 7 years

  • Vinia product is currently available to consumers in Israel, with US B2C introduction expected in early 2021

  • Over $30 Million CAD spent on Research and Development

  • Patented technology

  • Proven Management team on both Product Development and Commercialization

  • Low Cap Ex alternative to traditional agricuture that will allow scaleable production of ingredients such as hemp based CBD, grape, olive, and pomegranate products

Recent News Releases

Investor Inquiries

Join The Revolution